Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region.
The craniofacial region contains many specified tissues including bone, cartilage, muscle, blood vessels and neurons. Defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient's life. Therefore, functional reconstruction of damaged tissues is highly expected. Bone marrow-derived mesenchymal stem cells (BMMSCs) are one of the most well characterized postnatal stem cell populations, and considered to be utilized for cell-based clinical therapies. Here, the current understanding and the potential applications in craniofacial tissue regeneration of BMMSCs are reviewed, and the current limitations and drawbacks are also discussed.
Miura
M
M
Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Miura
Y
Y
Sonoyama
W
W
Yamaza
T
T
Gronthos
S
S
Shi
S
S
D000818:Animals; D001854:Bone Marrow Cells / Q000502:physiology*; D016026:Bone Marrow Transplantation; D005145:Face / Q000601:surgery; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000502:physiology*; D039902:Multipotent Stem Cells / Q000502:physiology; D012038:Regeneration / Q000502:physiology*; D012886:Skull / Q000601:surgery; D023822:Tissue Engineering